Emergent BioSolutions (EBS) Tops Q1 EPS by 22c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.18 --0%
EPS Growth %: -31.3%
Financial Fact:
Cost of product sales: 39.56M
Today's EPS Names:
H, FNGR, MHGU, More
EPS Growth %: -31.3%
Financial Fact:
Cost of product sales: 39.56M
Today's EPS Names:
H, FNGR, MHGU, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.71, $0.22 better than the analyst estimate of $0.49. Revenue for the quarter came in at $222.2 million versus the consensus estimate of $279 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi downgrades Ryder Systems to neutral, raises price target
- Kirby Corporation (KEX) PT Raised to $165 at Citi
- JPMorgan (JPM) call put ratio 2 calls to 1 put into the expected release of quarter results before the bell on July 14
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
